Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders Clinical research trials and Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders. Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders clinical trial. Subjects frequently obtain the most expert healthcare possible for their Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.

Home > "S" Clinical Trials Conditions > Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders

Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders



Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders

For Condition: X-linked hyper IgM syndrome,X-linked agammaglobulinemia,Wiskott-Aldrich Syndrome,Leukocyte Adhesion Deficiency Syndrome
Status: No longer recruiting
Sponsor(s): National Institute of Child Health and Human Development (NICHD) , University of Washington
Synopsis: OBJECTIVES: I. Identify the molecular defects responsible for primary immunodeficiency disorders. II. Explore the mutations within each syndrome to better understand the genetics of these disorders. III. Study the function of the Wiskott-Aldrich syndrome proteins (WASP). IV. Design methods to identify carriers and for prenatal diagnosis. V. Explore new avenues for therapy.
Details: PROTOCOL OUTLINE: Patients are studied systematically to determine the extent of their immune deficiency and to confirm a specific diagnosis. Patients with a known immunodeficiency syndrome are studied in detail to identify the gene mutation, to assess the effect of the mutation on the gene product, and to establish cell lines for further in vitro assessment of the genetic defect. The function of Wiskott-Aldrich syndrome proteins (WASP) in hematopoietic cells is studied. Family members of patients with X-linked disorders are studied to identify carrier females.
Eligibility:
Study Type:  Observational, Screening
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: Primary immunodeficiency disease, e.g.: Leukocyte adhesion deficiency syndrome Wiskott-Aldrich syndrome X-linked agammaglobulinemia X-linked hyper IgM syndrome
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
HansOchs,  Study Chair,  University of Washington

University of Washington School of Medicine
Seattle,  Washington,  98195
United States
 


Additional Information:
Study ID Numbers:  199/11900;  UW-533
Study Start Date: July 1995
Record last reviewed: October 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004341

Other Leukocyte Adhesion Deficiency Syndrome Studies:
1. Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders

2. Pilot Study of Allogeneic Bone Marrow Transplantation Plus Cyclosporine and Mycophenolate Mofetil to Induce Mixed Hematopoietic Chimerism in Patients With Primary T-Cell Immunodeficiency Disorders

3. Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies

Related Studies:

Other Leukocyte Adhesion Deficiency Syndrome Clinical Trials
Other Washington Clinical Trials
Other Seattle Clinical Trials

Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders
Modify your Search

  Other Leukocyte Adhesion Deficiency Syndrome Clinical Trials
  Other Washington Clinical Trials
  Other Seattle Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103